FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2300634849> ?p ?o ?g. }

• W2300634849 abstract "The aim of this study is to investigate the prognostic relevance of the best objective response of metastatic target lesions during sunitinib treatment in patients with metastatic renal cell carcinoma.Radiographic analysis of the best objective response according to the Response Evaluation Criteria in Solid Tumors was assessed in 50 patients. Clinicopathological characteristics including the Heng risk classification and sunitinib-related adverse reactions were compared among four patient subgroups [complete response or partial response (CR/PR), stable disease (SD), progressive disease (PD), and those without treatment evaluation (NE)]. Kaplan-Meier and Cox proportional regression analyses of progression-free survival and overall survival were performed to identify prognostic variables.The best objective response was CR/PR in 12 (24 %) patients, SD in 22 (44 %), PD in 6 (12 %), and NE in 10 (20 %). The incidence of hypertension and hypothyroidism was associated with a better objective response. Progression-free survival was 15.0, 9.2, 6.8, and 2.2 months in the CR/PR, SD, PD, and NE groups, respectively (P = 0.0004, log-rank test), while the corresponding median overall survival was 59.7, 24.2, 17.1, and 18.1 months, respectively (P = 0.007). Multivariate analysis revealed that hazard ratios for risk of death of the SD, PD, and NE groups were 4.51 (P = 0.06), 7.93 (P = 0.02), and 4.88 (P = 0.04), respectively, as compared to the CR/PR group.Our findings suggested that the best objective response of target lesions was a prognostic marker for both progression-free survival and overall survival in sunitinib treatment. Furthermore, the incidence of sunitinib-induced hypertension was associated with a longer progression-free survival." @default.
• W2300634849 created "2016-06-24" @default.
• W2300634849 creator A5000306803 @default.
• W2300634849 creator A5017624165 @default.
• W2300634849 creator A5018111348 @default.
• W2300634849 creator A5018716870 @default.
• W2300634849 creator A5019825512 @default.
• W2300634849 creator A5035555896 @default.
• W2300634849 creator A5039725947 @default.
• W2300634849 creator A5050544002 @default.
• W2300634849 creator A5056075642 @default.
• W2300634849 creator A5056692031 @default.
• W2300634849 creator A5064296815 @default.
• W2300634849 creator A5071529858 @default.
• W2300634849 creator A5078824656 @default.
• W2300634849 creator A5083149613 @default.
• W2300634849 creator A5083230671 @default.
• W2300634849 creator A5090942576 @default.
• W2300634849 date "2016-02-09" @default.
• W2300634849 modified "2023-10-06" @default.
• W2300634849 title "The best objective response of target lesions and the incidence of treatment-related hypertension are associated with the survival of patients with metastatic renal cell carcinoma treated with sunitinib: a Japanese retrospective study" @default.
• W2300634849 cites W1711115929 @default.
• W2300634849 cites W1973663909 @default.
• W2300634849 cites W1989821242 @default.
• W2300634849 cites W1998005755 @default.
• W2300634849 cites W2003621633 @default.
• W2300634849 cites W2019607817 @default.
• W2300634849 cites W2036515537 @default.
• W2300634849 cites W2049098629 @default.
• W2300634849 cites W2053874226 @default.
• W2300634849 cites W2059927424 @default.
• W2300634849 cites W2072006879 @default.
• W2300634849 cites W2099088585 @default.
• W2300634849 cites W2099752220 @default.
• W2300634849 cites W2102942754 @default.
• W2300634849 cites W2106591331 @default.
• W2300634849 cites W2106622364 @default.
• W2300634849 cites W2107567753 @default.
• W2300634849 cites W2113322173 @default.
• W2300634849 cites W2123534406 @default.
• W2300634849 cites W2141849536 @default.
• W2300634849 cites W2143782771 @default.
• W2300634849 cites W2145473922 @default.
• W2300634849 cites W2146147508 @default.
• W2300634849 cites W2155295247 @default.
• W2300634849 cites W2156408558 @default.
• W2300634849 cites W2991874119 @default.
• W2300634849 cites W4229808435 @default.
• W2300634849 doi "https://doi.org/10.1186/s13104-016-1895-8" @default.
• W2300634849 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4748467" @default.
• W2300634849 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26861149" @default.
• W2300634849 hasPublicationYear "2016" @default.
• W2300634849 type Work @default.
• W2300634849 sameAs 2300634849 @default.
• W2300634849 citedByCount "14" @default.
• W2300634849 countsByYear W23006348492016 @default.
• W2300634849 countsByYear W23006348492017 @default.
• W2300634849 countsByYear W23006348492018 @default.
• W2300634849 countsByYear W23006348492019 @default.
• W2300634849 countsByYear W23006348492020 @default.
• W2300634849 countsByYear W23006348492021 @default.
• W2300634849 countsByYear W23006348492022 @default.
• W2300634849 countsByYear W23006348492023 @default.
• W2300634849 crossrefType "journal-article" @default.
• W2300634849 hasAuthorship W2300634849A5000306803 @default.
• W2300634849 hasAuthorship W2300634849A5017624165 @default.
• W2300634849 hasAuthorship W2300634849A5018111348 @default.
• W2300634849 hasAuthorship W2300634849A5018716870 @default.
• W2300634849 hasAuthorship W2300634849A5019825512 @default.
• W2300634849 hasAuthorship W2300634849A5035555896 @default.
• W2300634849 hasAuthorship W2300634849A5039725947 @default.
• W2300634849 hasAuthorship W2300634849A5050544002 @default.
• W2300634849 hasAuthorship W2300634849A5056075642 @default.
• W2300634849 hasAuthorship W2300634849A5056692031 @default.
• W2300634849 hasAuthorship W2300634849A5064296815 @default.
• W2300634849 hasAuthorship W2300634849A5071529858 @default.
• W2300634849 hasAuthorship W2300634849A5078824656 @default.
• W2300634849 hasAuthorship W2300634849A5083149613 @default.
• W2300634849 hasAuthorship W2300634849A5083230671 @default.
• W2300634849 hasAuthorship W2300634849A5090942576 @default.
• W2300634849 hasBestOaLocation W23006348491 @default.
• W2300634849 hasConcept C10515644 @default.
• W2300634849 hasConcept C120665830 @default.
• W2300634849 hasConcept C121332964 @default.
• W2300634849 hasConcept C126322002 @default.
• W2300634849 hasConcept C143998085 @default.
• W2300634849 hasConcept C167135981 @default.
• W2300634849 hasConcept C207103383 @default.
• W2300634849 hasConcept C2777472916 @default.
• W2300634849 hasConcept C2778822529 @default.
• W2300634849 hasConcept C2779134260 @default.
• W2300634849 hasConcept C2779490328 @default.
• W2300634849 hasConcept C2779984678 @default.
• W2300634849 hasConcept C38180746 @default.
• W2300634849 hasConcept C44249647 @default.
• W2300634849 hasConcept C50382708 @default.
• W2300634849 hasConcept C61511704 @default.
• W2300634849 hasConcept C66339696 @default.
• W2300634849 hasConcept C71924100 @default.
• W2300634849 hasConcept C90924648 @default.

• next